• Protocols

• UW20100

  OPEN TO ACCRUAL

  Ph II Pre-Op Neratinib + Endocrine Therapy w/ Trastuzumab in Triple-Positive Breast Cancers
  
  

• UW25120

  OPEN TO ACCRUAL

  P2 Neoadjuvant Study of Zanidatamab in Combo with Chemotherapy in Participants with HER2-positive BC